Monte Rosa Therapeutics, Inc.

NASDAQ:GLUE

Biotechnology

Healthcare
$8.91 -1.39%

-$0.26 today

Market cap
$761.36M
Beta
1.60
P/E (TTM)
-9.1
EPS (TTM)
-$1.98
52W Low $4.12High $25.77

Volume 1.11M

Average 1.02M

Balance Sheet

Inspect the capital base behind the business.

Assets

$448.66M

FY 2025 · Annual

+2.3% YoY

Liabilities

$215.60M

FY 2025 · Annual

-0.1% YoY

Equity

$233.06M

FY 2025 · Annual

+4.5% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents346.07M54.91M128.1M224.25M129.88M
Short-term Investments0207.91M104.31M147.9M247.22M
Net Receivables07.66M505K173K4.6M
Inventory00000
Other Current Assets05.4M3.29M5.12M11.48M
Total Current Assets348.67M275.89M236.21M377.44M393.19M
Property, Plant & Equipment (Net)12.33M61.91M62.61M56.31M50.37M
Goodwill00000
Intangible Assets00000
Long-term Investments5.34M0000
Tax Assets00000
Other Non-current Assets04.6M4.93M4.98M5.1M
Total Non-current Assets17.66M66.5M67.54M61.29M55.47M
Total Assets366.33M342.39M303.76M438.73M448.66M
Account Payables6.56M7.86M11.15M17.22M3.55M
Short-term Debt00000
Tax Payables00000
Deferred Revenue0017.68M117.23M29.57M
Other Current Liabilities840K10.64M9.26M11.57M11.58M
Total Current Liabilities16.64M25.57M46.59M156.95M64.21M
Long-term Debt000034.79M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)0032.32M16.15M111.33M
Other Non-current Liabilities2.18M1.53M2.71M3.7M5.27M
Total Non-current Liabilities2.18M45.41M77.91M58.85M151.39M
Total Liabilities18.81M70.98M124.51M215.8M215.6M
Common Stock5K5K5K6K7K
Retained Earnings(122.04M)(230.54M)(365.89M)(438.59M)(477.21M)
Accumulated OCI(2.02M)(1.75M)(2.72M)(3.36M)(3.83M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity347.52M271.41M179.25M222.94M233.06M
Total Debt047M46.04M42.72M39.19M
Net Debt(346.07M)(7.91M)(82.06M)(181.54M)(90.69M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$159.9M
Short-term Investments$506.4M
Receivables$4.6M
Other Current$6.7M
Total Current Assets$677.5M
PP&E (Net)$53.1M
Other Non-current$5.8M
Total Non-current Assets$58.9M
Total Assets$736.4M

Analysis

Selected assets total $736.4M for Latest. The largest visible component is Short-term Investments at $506.4M, about 68.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 5, 2026
10-QQuarterly reportNov 5, 2026
4Statement of changes in beneficial ownershipOct 6, 2026
8-KCurrent reportOct 1, 2026
8-KCurrent reportSep 8, 2026

How much cash does GLUE have?

Monte Rosa Therapeutics, Inc. (GLUE) reported $129.88M in cash and equivalents in fiscal 2025.

How much debt does GLUE carry?

Monte Rosa Therapeutics, Inc. (GLUE) reported $39.19M of total debt, with net debt of -$90.69M.